Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit
Recently more and more cases of viral community-acquired pneumonia have been recorded. Laboratory markers (C-reactive protein, procalcitonin) can help diagnose this disease and determine its prognosis. When choosing an antimicrobial drug, data on antibiotic resistance, the presence of concomitant di...
Saved in:
| Main Author: | Yu. V. Evsutina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2021-06-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/268 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Community-Acquired Pneumonia in Children Caused by Pneumococci of MLSB- and M-Phenotype: Clinical Cases
by: Natalya A. Ilenkova, et al.
Published: (2017-06-01) -
Vaccination as a strategy to overcome antimicrobial resistance: a fresh look on a well-known problem
by: I. O. Stoma
Published: (2023-04-01) -
Adherence to SATS antibiotic recommendations in patients with community acquired pneumonia in Johannesburg, South Africa
by: Murimisi Mukansi, et al.
Published: (2016-04-01) -
SEROTYPES AND ANTIMICROBIAL SUSCEPTIBILITY OF NASOPHARYNGEAL PNEUMOCOCCI ISOLATED FROM CHILDREN IN 2010–2016: A RETROSPECTIVE COHORT STUDY
by: Nikolay A. Mayanskiy, et al.
Published: (2017-11-01) -
Pneumococcal carriage among young children attending daycare in Hungary, 12–13 years post-PCV13: a cross-sectional study
by: Andrea Horváth, et al.
Published: (2025-07-01)